Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Setanaxib in PBC with Elevated Alkaline Phosphatase
NCT03226067Phase 2Completed
- Sponsor
- Calliditas Therapeutics AB
- Start
- Jun 2017
- Primary completion
- Apr 2019
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of setanaxib in primary biliary cholangitis (PBC), sponsored by Calliditas Therapeutics AB. Started Jun 2017; status: completed.
02
Drugs
setanaxib
03
Conditions
primary biliary cholangitis (PBC)
Beyond the preview
Go deeper on NCT03226067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03226067.